Depression and heart failure

Hellenic Journal of Cardiology

Volumn 50, Issue 5, 2009, Pages 410-417

  Dimos, Apostolos K ^a   Stougiannos, Pavlos N ^a   Kakkavas, Apostolos T ^a   Trikas, Athanasios G ^a,b  

^a IASO GENERAL HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Antidepressant drugs; Depression; Heart failure

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUTE CORONARY SYNDROME; BRADYCARDIA; CLINICAL TRIAL; COGNITIVE THERAPY; CONGESTIVE HEART FAILURE; CONVALESCENCE; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; GENETIC POLYMORPHISM; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE CONTRACTILITY; HEART PROARRHYTHMIA; HUMAN; HYPERTENSIVE CRISIS; HYPOTENSION; MAJOR DEPRESSION; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PROTHROMBIN TIME; PSYCHOLOGICAL RATING SCALE; QT PROLONGATION; REVIEW; SIDE EFFECT; TACHYCARDIA;

DEPRESSION; HEART FAILURE; HUMANS; PROGNOSIS;

EID: 70349680638     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology. 1993; 4: 285-294. (Pubitemid 23199705)
2. Carney RM, Freedland KE, Sheline YI, Weiss ES. Depression and coronary heart disease: a review for cardiologists. Clin Cardiol. 1997; 20: 196-200. (Pubitemid 27120153)
3. Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA. 2006; 295: 2874-2881.
4. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA. 1993; 270: 1819-1825.
5. Joynt KE, Whellan DJ, O'Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail. 2004; 10: 258-271.
6. Carney RM, Howells WB, Blumenthal JA, et al. Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med. 2007; 69: 4-9. (Pubitemid 46148359)
7. Lesperance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med. 1996; 58: 99-110. (Pubitemid 126425883)
8. Lee HJ, Cha JH, Ham BJ, et al. Association between a Gprotein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J. 2004; 4: 29-33.
9. Poch E, Gonzalez D, Gomez-Angelats E, et al. G-Protein beta( 3) subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension. 2000; 35: 214-218.
10. Parissis JT, Fountoulaki K, Paraskevaidis I, Kremastinos D. Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches. Expert Opin Investig Drugs. 2005; 14: 567-577. (Pubitemid 40790279)
11. Parissis JT, Adamopoulos S, Rigas A, et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol. 2004; 94: 1326-1328. (Pubitemid 39469963)
12. Ferketich AK, Ferguson JP, Binkley PF. Depressive symptoms and inflammation among heart failure patients. Am Heart J. 2005; 150: 132-136. (Pubitemid 41097440)
13. Serebruany VL, Glassman AH, Malinin AI, et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation. 2003; 108: 939-944. (Pubitemid 37048222)
14. Redwine LS, Mills PJ, Hong S, et al. Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in heart failure patients. Psychosom Med. 2007; 69: 23-29. (Pubitemid 46148361)
15. Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV. Chronotropic and neurohumoral markers for the evaluation of functional capacity in patients with impaired left ventricular function. Hellenic J Cardiol. 2008; 49: 26-32.
16. Spiraki C, Kaitelidou D, Papakonstantinou V, Prezerakos P, Maniadakis N. Health-related quality of life measurement in patients admitted with coronary heart disease and heart failure to a cardiology department of a secondary urban hospital in Greece. Hellenic J Cardiol. 2008; 49: 241-247.
17. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure. 1977; 1: 385-401.
18. Depression Guidelines Panel. In: Depression in Primary Care: Detection and Diagnosis: US Department of Health and Human Services. Public Health Service. 1993: AHCPR publication no. 93-0550.
19. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965; 12: 63-70.
20. Zung WW. Factors influencing the self-rating depression scale. Arch Gen Psychiatry. 1967; 16: 543-547.
21. Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol. 1993; 22: 3A-5A. (Pubitemid 23285788)
22. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998; 55: 580-592.
23. Friedman MM, Griffin JA. Relationship of physical symptoms and physical functioning to depression in patients with heart failure. Heart Lung. 2001; 30: 98-104. (Pubitemid 32225933)
24. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol. 1999; 84: 348-50, A9.
25. Skotzko CE, Krichten C, Zietowski G, et al. Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail. 2000; 6: 300-305. (Pubitemid 32051877)
26. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J. 2004; 25: 492-499. (Pubitemid 38524274)
27. Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 2001; 38: 199-205. (Pubitemid 32613851)
28. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001; 161: 1849-1856. (Pubitemid 32762729)
29. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006; 48: 1527-1537. (Pubitemid 44528168)
30. Jiang W, Kuchibhatla M, Clary GL, et al. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J. 2007; 154: 102-108. (Pubitemid 46920483)
31. Parissis JT, Nikolaou M, Farmakis D, et al. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart. 2008; 94: 585-589. (Pubitemid 351580132)
32. Fulop G, Strain JJ, Stettin G. Congestive heart failure and depression in older adults: clinical course and health services use 6 months after hospitalization. Psychosomatics. 2003; 44: 367-373. (Pubitemid 37071923)
33. Ahmed A, Allman RM, Kiefe CI, et al. Association of consultation between generalists and cardiologists with quality and outcomes of heart failure care. Am Heart J. 2003; 145: 1086-1093. (Pubitemid 36688262)
34. Krishnan KR, George LK, Pieper CF, et al. Depression and social support in elderly patients with cardiac disease. Am Heart J. 1998; 136: 491-495. (Pubitemid 28413548)
35. Zich JM, Attkisson CC, Greenfield TK. Screening for depression in primary care clinics: the CES-D and the BDI. Int J Psychiatry Med. 1990; 20: 259-277.
36. Papathanasiou G, Tsamis N, Georgiadou P, Adamopoulos S. Beneficial effects of physical training and methodology of exercise prescription in patients with heart failure. Hellenic J Cardiol. 2008; 49: 267-277.
37. Krittayaphong R, Cascio WE, Light KC, et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med. 1997; 59: 231-235. (Pubitemid 27240723)
38. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341: 709-717.
39. Hansten PD, Horn JR. Hansten's and Horn's Drug Interactions Analysis and Management. Vancouver: WA: Applied Therapeutics; 1997.
40. Murray L, ed. Physician's Desk Reference. 56th ed. Montvale, NJ: Medical Economics; 2002: 1685.
41. Roose SP, Glassman AH, Attia E, et al. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry. 1998; 155: 660-665. (Pubitemid 28225407)
42. Glassman AH, Johnson LL, Giardina EG, et al. The use of imipramine in depressed patients with congestive heart failure. JAMA. 1983; 250: 1997-2001.
43. Roose SP, Glassman AH, Giardina EG, et al. Nortriptyline in depressed patients with left ventricular impairment. JAMA. 1986; 256: 3253-3257. (Pubitemid 17191690)
44. Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs. 1999; 57: 507-533. (Pubitemid 29196919)
45. Walley T, Pirmohamed M, Proudlove C, Maxwell D. Interaction of metoprolol and fluoxetine. Lancet. 1993; 341: 967-968.
46. Rasmussen SL, Overo KF, Tanghoj P. Cardiac safety of citalopram: prospective trials and retrospective analyses. J Clin Psychopharmacol. 1999; 19: 407-415. (Pubitemid 29451505)
47. Gottlieb SS, Kop WJ, Thomas SA, et al. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. Am Heart J. 2007; 153: 868-873.
48. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002; 288: 701-709. (Pubitemid 34848222)
49. Jiang W, O'Connor C, Silva SG, et al. Safety and efficacy of sertraline for depression in patients with CHF (SADHARTCHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J. 2008; 156: 437-444.
50. O'Connor C. Safety and Efficacy of Sertraline for Depression in Patients with Congestive Heart Failure (SADHARTCHF). Heart Failure Society of America 2008 Scientific Meeting; September 22, 2008; Toronto, ON. Late Breaking Clinical Trials I.